Roy Fleischmann
Is this you? Claim this profileThis page collects the articles indexed under the name Roy Fleischmann. Profiles are grouped by name, so it can include work by someone else who shares it until the author claims the profile and confirms which papers are theirs.
Publications 5
- efficacy and safety of sarilumab in combination with csdmards or as monotherapy in subpopulations of patients with moderately to severely active rheumatoid arthritis in three phase iii randomized, controlled studies
- Background Glucocorticoid Therapy Has No Impact on Efficacy and Safety of Abatacept or Adalimumab in Patients with Rheumatoid Arthritis
- a summary of 2018 and what lies ahead for rheumatology and therapy in 2019
- 221 Development of abatacept- and adalimumab-specific predictive models of response to therapy in rheumatoid arthritis using data from a head-to-head study
- 221 Development of abatacept- and adalimumab-specific predictive models of response to therapy in rheumatoid arthritis using data from a head-to-head study
Possible papers by Roy Fleischmann 1
Published under a similar spelling of the name. Beside each paper is the evidence that it may be the same person, strongest first; "Same name only" means there is nothing else to go on.
-
Alignment of whole genomes
Same name only
Under these spellings
-
R. D. Fleischmann 1 article
Same person? Claim this profile, then add these papers one by one or combine a whole spelling.
Is this you?
Claim this profile to connect it to your account. You will be able to remove papers that are not yours, fold in other spellings of your name, and show your affiliation and photo here.
Institutions on these papers
- Metroplex Clinical Research Center · US 2
From OpenAlex, for papers with a DOI.